Wells Fargo Maintains Overweight on Globus Medical, Raises Price Target to $100
Benzinga Newsdesk 12 hours ago
Analyst RatingsNewsPrice Target
Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $99 to $100.
Wells Fargo analyst Larry Biegelsen maintains Globus Medical (NYSE:GMED) with a Overweight and raises the price target from $99 to $100.